LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade
Exhausted CD8+ T cells are key targets of immune checkpoint blockade therapy and their ineffective reinvigoration limits the durable benefit in some cancer patients. Here, we demonstrate that histone demethylase LSD1 acts to enforce an epigenetic program in progenitor exhausted CD8+ T cells to antag...
Principais autores: | Liu, Y, Debo, B, Li, M, Shi, Z, Sheng, W, Shi, Y |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Springer Nature
2021
|
Registros relacionados
-
Simultaneous inhibition of LSD1 and TGFβ enables eradication of poorly immunogenic tumors with Anti-PD-1 treatment
por: Sheng, W, et al.
Publicado em: (2021) -
LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade
por: Sheng, W, et al.
Publicado em: (2018) -
Biomarkers of response to PD-1 pathway blockade
por: Li, H, et al.
Publicado em: (2022) -
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
por: Dushek, O, et al.
Publicado em: (2016) -
Taking LSD 1 to a new high.
por: Wysocka, J, et al.
Publicado em: (2005)